Wall Street Experts
ver. ZuMIgo(08/25)
Ovid Therapeutics Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 1
EBIT TTM (mln): -67
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
Rok finansowy |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
13 |
208 |
2 |
0 |
1 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
inf% |
1551.6% |
-99.3% |
-73.9% |
44.5% |
Marża brutto |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-inf% |
100.0% |
100.0% |
8.1% |
-307.6% |
100.0% |
EBIT (mln) |
-0 |
-13 |
-23 |
-65 |
-53 |
-61 |
-81 |
124 |
-56 |
-59 |
-62 |
EBIT Δ r/r |
0.0% |
2851.6% |
70.8% |
188.5% |
-18.6% |
16.0% |
32.6% |
-252.5% |
-144.7% |
6.7% |
4.4% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-645.4% |
59.6% |
-3696.4% |
-15134.6% |
-10933.7% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-3 |
0 |
0 |
EBITDA (mln) |
-0 |
-13 |
-22 |
-65 |
-53 |
-61 |
-81 |
124 |
-56 |
-58 |
-62 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-645.4% |
59.7% |
-3696.4% |
-14727.0% |
-10933.7% |
Podatek (mln) |
0 |
0 |
-0 |
-0 |
1 |
-1 |
-0 |
1 |
-3 |
0 |
0 |
Zysk Netto (mln) |
-0 |
-13 |
-22 |
-65 |
-52 |
-59 |
-81 |
123 |
-51 |
-52 |
-26 |
Zysk netto Δ r/r |
0.0% |
2844.8% |
70.3% |
189.1% |
-19.8% |
14.0% |
36.2% |
-252.2% |
-141.9% |
1.8% |
-49.5% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-639.8% |
58.9% |
-3421.0% |
-13362.2% |
-4670.1% |
EPS |
-0.094 |
-0.67 |
-1.14 |
-3.35 |
-2.11 |
-1.51 |
-1.38 |
1.78 |
-0.73 |
-0.74 |
-0.37 |
EPS (rozwodnione) |
-0.094 |
-0.67 |
-1.14 |
-3.35 |
-2.11 |
-1.51 |
-1.38 |
1.78 |
-0.73 |
-0.74 |
-0.37 |
Ilośc akcji (mln) |
5 |
20 |
20 |
19 |
25 |
39 |
58 |
67 |
70 |
71 |
71 |
Ważona ilośc akcji (mln) |
5 |
20 |
20 |
19 |
25 |
39 |
58 |
68 |
70 |
71 |
71 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |